Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.

    Advocates Ask that the Same Effort Used for COVID Drug Discovery Be Used for Rare Diseases

    Dr. Christopher Austin, a National Institute of Health Director for Transitional Sciences, spoke at last year’s virtual conference honoring Rare Disease Day. According to an article in the NIH Record, Dr.…

    Continue Reading Advocates Ask that the Same Effort Used for COVID Drug Discovery Be Used for Rare Diseases

    Study Identifies People with Idiopathic Pulmonary Arterial Hypertension at Greatest Risk of Death

    Korea began its use of effective therapies for idiopathic pulmonary arterial hypertension (IPAH) early in 2000. Idiopathic hypertension has no apparent cause. Yet there have been very few studies assessing…

    Continue Reading Study Identifies People with Idiopathic Pulmonary Arterial Hypertension at Greatest Risk of Death
    An Innocent-Looking Shadow on Her Thumbnail Turned Out to be Subungual Melanoma
    Source: https://pixabay.com/en/thumb-up-like-sign-hand-ok-good-441938/

    An Innocent-Looking Shadow on Her Thumbnail Turned Out to be Subungual Melanoma

    Maria’s message is: “when in doubt, get a biopsy." Ten years ago, Maria Sylvia noticed a vertical streak on her thumbnail that at the time she thought was “cool." She…

    Continue Reading An Innocent-Looking Shadow on Her Thumbnail Turned Out to be Subungual Melanoma
    Thousands of Children are Waiting for FDA’s Approval of IMBRUVICA for Pediatric Graft-Versus-Host Disease
    source: pixabay.com

    Thousands of Children are Waiting for FDA’s Approval of IMBRUVICA for Pediatric Graft-Versus-Host Disease

      Every year almost half of the fourteen thousand patients who have received bone marrow or stem cell transplants will develop chronic graft-versus-host disease (cGVHD). Currently, there are no options…

    Continue Reading Thousands of Children are Waiting for FDA’s Approval of IMBRUVICA for Pediatric Graft-Versus-Host Disease

    Johns Hopkins Researchers Use Primary Immunodeficiencies to Discover New Info About Immune System Cells

      The COVID era emphasized the importance of maintaining a strong immune system. But what about people who are less fortunate? Johns Hopkins researchers recently announced some good news for…

    Continue Reading Johns Hopkins Researchers Use Primary Immunodeficiencies to Discover New Info About Immune System Cells

    DIY: A Pulmonary Hypertension Patient Drains His Lungs at Home

    Roger Bliss, 68-year-old pulmonary hypertension (PH) patient, was diagnosed with chronic lymphocytic leukemia and small lymphocytic lymphoma. In addition, Roger has celiac disease. He recently interviewed with Pulmonary Hypertension News.…

    Continue Reading DIY: A Pulmonary Hypertension Patient Drains His Lungs at Home

    Transthyretin Amyloidosis: CRISPR-Cas9 Technology Shows Results in a Single Treatment

    In August of 2021, Intellia Therapeutics of Cambridge and its partner Regeneron Pharmaceuticals published a study reported in the Boston Globe, showing results of a single treatment using CRISPR-Cas9 technology.…

    Continue Reading Transthyretin Amyloidosis: CRISPR-Cas9 Technology Shows Results in a Single Treatment

    A UConn Health Team Administers the World’s First Gene Therapy for Glycogen Storage Disease Type-1a

    In January of this year, a University of Connecticut (UConn) team administered the world’s first infusion of a new gene therapy as part of a long-awaited clinical trial. According to…

    Continue Reading A UConn Health Team Administers the World’s First Gene Therapy for Glycogen Storage Disease Type-1a